Imexon and Gemcitabine: Mechanisms of Synergy against Human Pancreatic Cancer
Imexon is an iminopyrrolidone aziridine which previously has shown activity against a variety of human cancer types, including multiple myeloma and pancreatic adenocarcinoma. Recently, mechanistic studies in the MIA PaCa-2 human pancreatic cancer cell line have demonstrated binding to sulfhydryls, b...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | EN |
| Published: |
The University of Arizona.
2005
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/194494 |